400-920-2911 sales@csnpharm.cn
您的位置 : 首页 / PI3K/Akt/mTOR / Akt / GSK2110183 analog 1
CAS No.: 1047634-63-8
Synonyms: Afuresertib-F;GSK-2110183-analog;Afuresertib-F free base
GSK2110183 analog is an analog of GSK2110183.
生物活性
NCT号 | 适应症或疾病 | 临床期 | 招募状态 | 预计完成时间 | 地点 |
---|---|---|---|---|---|
NCT01827644 | Cancer | Phase 1 | Completed | - | Australia, Victoria ... more >> GSK Investigational Site Melbourne, Victoria, Australia, 3004 Collapse << |
NCT00881946 | Hematologic Malignancies | Phase 1 Phase 2 | Completed | - | Australia, New South Wales ... more >> Prince of Wales Hospital Sydney, New South Wales, Australia, 2031 Australia, Victoria The Alfred Hospital Melbourne, Victoria, Australia, 3004 Canada, Ontario Princess Margaret Hospital Toronto, Ontario, Canada, M5G 2M9 Korea, Republic of Seoul National University Hospital Seoul, Korea, Republic of, 110-744 Collapse << |
NCT02040480 | Cancer | Phase 1 | Completed | - | Australia, New South Wales ... more >> GSK Investigational Site Randwick, New South Wales, Australia, 2031 Collapse << |
实验方案
技术信息
CAS号 | 1047634-63-8 | 储存条件 |
|
|
分子式 | C18H16Cl2F2N4OS | 运输 | 蓝冰 | |
分子量 | 445.31 | 别名 | Afuresertib-F;GSK-2110183-analog;Afuresertib-F free base |
NCT号 | 适应症或疾病 | 临床期 | 招募状态 | 预计完成时间 | 地点 |
---|
NCT01827644 | Cancer | Phase 1 | Completed | - | Australia, Victoria ... more >> GSK Investigational Site Melbourne, Victoria, Australia, 3004 Collapse << |
NCT00881946 | Hematologic Malignancies | Phase 1 Phase 2 | Completed | - | Australia, New South Wales ... more >> Prince of Wales Hospital Sydney, New South Wales, Australia, 2031 Australia, Victoria The Alfred Hospital Melbourne, Victoria, Australia, 3004 Canada, Ontario Princess Margaret Hospital Toronto, Ontario, Canada, M5G 2M9 Korea, Republic of Seoul National University Hospital Seoul, Korea, Republic of, 110-744 Collapse << |
NCT02040480 | Cancer | Phase 1 | Completed | - | Australia, New South Wales ... more >> GSK Investigational Site Randwick, New South Wales, Australia, 2031 Collapse << |
NCT01531894 | Cancer | Phase 2 | Completed | - | United States, Maryland ... more >> Novartis Investigative Site Baltimore, Maryland, United States, 21231 United States, Massachusetts Novartis Investigative Site Boston, Massachusetts, United States, 02115 United States, New York Novartis Investigative Site New York, New York, United States, 10029 Novartis Investigative Site New York, New York, United States, 10065 Australia, Victoria Novartis Investigative Site Melbourne, Victoria, Australia, 3004 Canada, Ontario Novartis Investigative Site Toronto, Ontario, Canada, M5G 1Z6 Ireland Novartis Investigative Site Galway, Ireland Korea, Republic of Novartis Investigative Site Seoul, Korea, Republic of, 110-744 Collapse << |
NCT01476137 | Cancer | Phase 1 | Completed | - | United States, Texas ... more >> GSK Investigational Site Dallas, Texas, United States, 75246 GSK Investigational Site San Antonio, Texas, United States, 78229 Collapse << |
NCT01653912 | Recurrent Platinum-resistant O... more >>varian Cancer Collapse << | Phase 1 Phase 2 | Completed | - | Australia, Queensland ... more >> Royal Brisbane and Women's Hospital Herston, Queensland, Australia, 4029 Australia, Victoria Peter MacCallum Cancer Centre East Melbourne, Victoria, Australia, 8006 Western Hospital Footscray, Victoria, Australia, 3011 Royal Women's Hospital Parkville, Victoria, Australia, 3052 Australia, Western Australia Sir Charles Gairdner Hospital Nedlands, Western Australia, Australia, 6009 Russian Federation Medical Radiology Scientific Center of Ministry of Healthcare and Social Development of RF Omskaya, Russian Federation, 249036 City Clinical Oncology Dispensary Saint-Petersburg, Russian Federation, 198255 United Kingdom Mount Vernon Cancer Center Northwood, Middlesex, London, United Kingdom, HA6 2RN Royal Surrey County Hospital NHS Foundation Trust Guildford, Surry, United Kingdom, GU2 7XP Imperial College Healthcare NHS Trust London, United Kingdom, W 12 0HS Collapse << |
NCT01428492 | Multiple Myeloma | Phase 1 | Completed | - | United States, Arizona ... more >> Novartis Investigative Site Scottsdale, Arizona, United States, 85259 United States, California Novartis Investigative Site Duarte, California, United States, 91010 United States, Georgia Novartis Investigative Site Atlanta, Georgia, United States, 30322 United States, Illinois Novartis Investigative Site Chicago, Illinois, United States, 60637 United States, New York Novartis Investigative Site New York, New York, United States, 10029 United States, North Carolina Novartis Investigative Site Chapel Hill, North Carolina, United States, 27599-7305 United States, Ohio Novartis Investigative Site Columbus, Ohio, United States, 43210 United States, Wisconsin Novartis Investigative Site Madison, Wisconsin, United States, 53792 Australia, Victoria Novartis Investigative Site Melbourne, Victoria, Australia, 3004 Canada, British Columbia Novartis Investigative Site Vancouver, British Columbia, Canada, V5Z 1M9 Canada, Ontario Novartis Investigative Site Toronto, Ontario, Canada, M5G 2M9 Ireland Novartis Investigative Site Galway, Ireland Taiwan Novartis Investigative Site Taipei, Taiwan, 100 Collapse << |
NCT01395004 | Langerhans Cell Histiocytosis | Phase 2 | Completed | - | United States, Maryland ... more >> Johns Hopkins Hospital Baltimore, Maryland, United States, 21287 United States, Massachusetts Dana Farber Cancer Institute Boston, Massachusetts, United States, 02115 United States, New York Memorial Sloan Kettering Cancer Center New York, New York, United States, 10065 Staten Island University Hospital Staten Island, New York, United States, 10305 United States, Texas Baylor College of Medicine Houston, Texas, United States, 77030 Collapse << |
NCT01445587 | Cancer | Phase 2 | Withdrawn(Based on the clinica... more >>l activity, not safety data, of the AKT inhibitor, GSK has decided at this time to suspend further development of GSK2110183 as monotherapy.) Collapse << | November 2011 | Australia, Victoria ... more >> GSK Investigational Site Melbourne, Victoria, Australia, 3004 Collapse << |
NCT01532700 | Chronic Lymphocytic Leukemia (... more >>CLL) Collapse << | Phase 2 | Completed | - | Canada, Ontario ... more >> University Health Network-Princess Margaret Hospital Toronto, Ontario, Canada, M5G 2M9 Collapse << |
NCT01653912 | - | - | Completed | - | - |
联系我们
官方电话:400-920-2911
二维码
微信公众号 CSN官网